---
title: 'AI Scientist - Entrepreneur in Residence at molecule.xyz'
canonical: 'https://feeny.ai/job/ai-scientist-entrepreneur-in-residence-molecule-xyz-remote-akb2jmnwjk5c'
type: 'job'
last_seen: '2026-09-13'
---

# AI Scientist - Entrepreneur in Residence at molecule.xyz

- **Company:** molecule.xyz
- **Location:** Remote
- **Employment:** full-time
- **Work type:** remote
- **Posted:** 2026-05-20
- **Last confirmed live:** 2026-09-13
- **Apply:** https://jobs.ashbyhq.com/molecule/e87bfa67-10e2-4d58-97bc-89b5a5d91c2c

## Job description

Molecule and BIO.xyz are building the foundation of Decentralized Science (DeSci) — where biotech meets web3 to make scientific research community-owned, transparent, and faster to market. Molecule provides the infrastructure to turn intellectual property (IP) into programmable, on-chain assets through our IP-NFT framework and evolving protocol stack. This enables researchers, patients, and communities to fund and govern biotech projects in new, open ways. [BIO.xyz](http://Bio.xyz) is the coordination and economic layer of DeSci, powering BioDAOs through funding, governance, and ecosystem alignment. Together, we are creating a new model for scientific discovery — one where breakthroughs are owned and advanced by the communities that believe in them.

## The Role

You will be an AI Scientist at Molecule. In your first four weeks, you will live on-site, embedded with the founding team, and ship your first autonomous agent fleet into production against a real disease area. From day one you own the loop: design the agents, deploy them, pilot them, iterate, and generate scientific output that moves IP forward. This is not a research role with a roadmap handed to you. You will pick targets, stand up infrastructure, recruit your sub-agents, and prove that autonomous science works at the bench-to-IP level. After the residency, you scale: more fleets, more disease areas, more shots on goal.

## What You'll Do

- Architect and deploy fleets of scientific agents spanning literature mining, target identification, molecular design, assay design, and data analysis
- Pilot each fleet against a specific disease area and drive it to a tangible deliverable — a validated target, a candidate molecule, a novel dataset, an IP-NFT
- Run multiple fleets in parallel across disease areas, reporting results directly to the CEO
- Own the full stack: agent design, orchestration, evaluation, and scientific judgment on outputs
- Define and set the standard for how autonomous science gets done at Molecule

## Who You Are

- Entrepreneurial to the core. You ship. You don't wait for permission.
- Technically deep across LLMs, agent frameworks, and at least one wet-science domain - chemistry, biology, pharma, structural biology, or genomics
- Comfortable with ambiguity. You may be the only person in the room who knows how to do what you do, and that energizes you
- Credential-agnostic. PhD, MSc, BSc, or straight from high school - output matters, not titles. If you hold a degree, it should be from a top-tier institution (Oxbridge, Ivy League, MIT, Caltech, Stanford, ETH/EPFL, Imperial, or equivalent). If you skipped the degree, show us what you built instead.
- All-in on intensity. Willing to live on-site for 4 weeks and operate at founder pace

## What We Offer

- An early seat at the company building the infrastructure for autonomous science
- Direct ownership over a frontier no one else is running at
- Equity in the form of $BIO token allocation
- The fastest path from idea to deployed IP that exists in biotech today

We are an equal opportunity employer. We are committed to equality and weaving a community that values diverse perspectives and experiences and are actively seeking a diverse pool of applicants. All employment decisions are made without regard to race, colour, national origin, ancestry, sex, gender, gender identity or expression, sexual orientation, age, genetic information, religion, disability, medical condition, pregnancy, marital status, family status, veteran status, or any other characteristic protected by law.

## About molecule.xyz

## Company Overview
- **One-liner**: Molecule builds onchain infrastructure for tokenizing, funding, and accelerating scientific research, enabling autonomous AI-driven science and liquid intellectual property markets.
- **Entity Type**: Private (Web3 / DeSci startup)
- **Headquarters**: Not publicly available (remote-first, team distributed globally)
- **Founded**: 2020
- **Founders**: Paul Kohlhaas (Founder and Chairman), Aaron Weaver (Chief Commercial Officer, Co-Founder)

## Core Business
- **Primary industry**: Decentralized Science (DeSci), Biotechnology, Web3 Infrastructure
- **Target customers**: Researchers, biotech labs, scientific institutions, Web3 investors, AI agent developers, and pharmaceutical companies
- **Mission**: "Propel science from lab to life, fueled by a community committed to human progress" — democratizing drug development and scientific research funding through onchain infrastructure.

## Products & Services
- **Onchain Lab**: A modular smart contract wallet (ERC-7579) that acts as a sovereign, programmable container for research projects. It holds assets, executes transactions, stores data references, and interacts with protocols under a persistent onchain identity. Supports IP tokenization, fractionalized ownership, and AI agent execution.
- **IP-NFTs & IP Tokens**: Tokenization of intellectual property as NFTs, with fractionalized ownership via tokens, enabling liquid markets for scientific IP, crowdsales, and automated royalty/licensing via smart contracts.
- **Data Infrastructure & DeSci API**: Decentralized data storage (IPFS, Arweave) with provenance tracking, encryption, and granular access control (token-gated, credential-gated, payment-gated). The DeSci API provides programmatic read/write access to Lab data rooms.
- **BioAgents (AI Agent Layer)**: An open-source AI scientist framework (by bio.xyz) integrated as an executor module on Labs. Agents autonomously analyze data, generate hypotheses, and publish findings with full onchain provenance, operating in Fully Autonomous or Human-Directed modes.

## Market Standing
- **Valuation**: Not publicly disclosed
- **Total Funding**: Not publicly disclosed (backed by prominent Web3 and DeSci investors)
- **Notable Investors/Partners**: bio.xyz (ecosystem partner), community of scientists, researchers, and Web3 investors; part of the broader DeSci movement alongside projects like VitaDAO
- **Growth Signals**: Molecule has been operating for over 5 years, evolving from a coordination layer to a full programmable science economy. The launch of "Labs" architecture (Feb 2026) represents a major technical evolution, integrating AI agents (BioAgents) and modular smart contract standards (ERC-4337, ERC-6551, ERC-7579). The platform has successfully tokenized multiple real-world biopharma IP assets, creating a growing ecosystem of onchain science.

## Competitive Advantages
- **First-mover in DeSci infrastructure**: Molecule is one of the earliest and most established platforms for tokenizing biopharma IP onchain, with a track record of real-world scientific assets.
- **Integrated AI agent layer**: The BioAgents integration creates a closed loop where AI agents autonomously operate within Labs, generating hypotheses and analyzing data with full onchain provenance — a unique moat in scientific research infrastructure.
- **Modular, standards-based architecture**: Built on ERC-4337, ERC-6551, and ERC-7579, Labs are sovereign, transferable, and extensible — allowing new capabilities (licensing, governance, oracles) to be installed over time.
- **Liquid IP markets**: IP-NFTs and IP Tokens make traditionally illiquid scientific intellectual property tradable, fractionalizable, and investable — creating a new asset class.

## Strategic Focus
- **Scaling the Labs ecosystem**: Transitioning from a coordination layer to a full programmable science economy where researchers can go from idea to market entirely onchain.
- **AI agent integration**: Deepening the integration of autonomous AI agents (BioAgents) to enable continuous, self-driving scientific research within Labs.
- **Building developer and researcher adoption**: Growing the ecosystem of modules, integrations, and users around the Onchain Lab standard.
- **Tokenizing real-world biopharma IP**: Continuing to bring high-value scientific assets onchain, creating liquid markets for intellectual property.

## Why Work Here
- **Mission-driven**: Directly contribute to accelerating cures and democratizing science funding — work that has tangible impact on human health and progress.
- **Remote-first, global team**: Distributed team with multiple in-person off-sites per year; strong emphasis on autonomy and ownership.
- **Competitive compensation**: Salary + token + equity packages benchmarked against leading biotech and Web3 companies.
- **Generous benefits**: PTO, learning & development budget, paid travel to conferences and scientific events, team off-sites.
- **High-agency culture**: Values include purpose, innovation, autonomy, care, and high standards. The team moves fast, communicates clearly, and values scientific curiosity and operational rigor.
- **Hiring process**: Application → screening → practical hiring challenge (domain-specific) → interviews with teammates and leadership → decision within days. Designed to mimic real work, not trivia.
- **Open roles**: Senior Product Manager, Senior Web3 Engineer, Senior Finance Manager, Full Stack Engineer, dApp Protocol Engineer, and more — all listed on [jobs.ashbyhq.com/molecule](https://jobs.ashbyhq.com/molecule).

## Sources
1. [molecule.xyz](https://molecule.xyz/about-us)
2. [molecule.xyz](https://molecule.xyz/careers)
3. [docs.molecule.xyz](https://docs.molecule.xyz/)
4. [molecule.xyz](https://molecule.xyz/blog/inside-molecules-biggest-technical-overhaul)
5. [molecule.xyz](https://www.molecule.xyz/how-it-works)
6. [jobs.ashbyhq.com](https://jobs.ashbyhq.com/molecule)

## Other roles at molecule.xyz

- [Pharmacist](https://feeny.ai/job/pharmacist-molecule-xyz-germany-s3pkq7vsmz3q) — Germany
- [Paralegal](https://feeny.ai/job/paralegal-molecule-xyz-remote-ant91m71jy2q)
- [CEO Attaché](https://feeny.ai/job/ceo-attache-molecule-xyz-remote-tvc8fp16qp6k)